{"id":6078,"date":"2022-12-15T11:12:00","date_gmt":"2022-12-15T11:12:00","guid":{"rendered":"https:\/\/genekor.dermtherapy.gr\/2023\/12\/07\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/"},"modified":"2024-03-04T15:08:59","modified_gmt":"2024-03-04T15:08:59","slug":"scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar","status":"publish","type":"post","link":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/","title":{"rendered":"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar"},"content":{"rendered":"\n<p>Studiul echipei \u0219tiin\u021bifice Genekor privind<strong> Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar<\/strong>\u00bb \u00ab<strong>Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar<\/strong>\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"512\" src=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer.jpg\" alt=\"\" class=\"wp-image-5614\" srcset=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer.jpg 1024w, https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer-300x150.jpg 300w, https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer-768x384.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Scorul de risc poligenic este un instrument folosit pentru a identifica \u0219i calcula riscul de a dezvolta cancer mamar pe parcursul vie\u021bii \u0219i, prin urmare, investig\u0103m dac\u0103 poate fi utilizat \u00eentr-o cohort\u0103 de 105 de pacien\u021bi pentru a identifica acest risc.<\/p>\n\n\n\n<p>Concluziile la care a ajuns echipa \u0219tiin\u021bific\u0103 Genekor sunt:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>PRS poate ajuta la estimarea riscului de a dezvolta cancer mamar la aproximativ 30% dintre persoanele cu rezultate negative la test\u0103rile genetice.<\/li>\n\n\n\n<li>\u00cen comun, se estimeaz\u0103 c\u0103 alterarea patogen\u0103 a genelor cu risc \u00eenalt \u0219i intermediar (20%) \u0219i PRS (30%) justific\u0103 50% dintre femeile cu risc de a dezvolta cancer mamar.<\/li>\n\n\n\n<li>PRS nu pare s\u0103 poat\u0103 ajuta la \u00eembun\u0103t\u0103\u021birea estim\u0103rii riscului la purt\u0103torii de modific\u0103ri ale genelor cu risc intermediar, dar ajut\u0103 la genele cu risc sc\u0103zut.<\/li>\n<\/ul>\n\n\n\n<p><strong>Pentru a citi posterul click <a href=\"https:\/\/www.genekor.com\/media\/1882\/poster-tsoulos-prs-sabcs-2022.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">aici.<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Studiul echipei \u0219tiin\u021bifice Genekor privind Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar\u00bb \u00abStudiul echipei \u0219tiin\u021bifice [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":6079,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33],"tags":[],"class_list":["post-6078","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-ro"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.0 (Yoast SEO v24.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar - Genekor<\/title>\n<meta name=\"description\" content=\"Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar\" \/>\n<meta property=\"og:description\" content=\"Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-15T11:12:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-04T15:08:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Vassia Lagou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Vassia Lagou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\"},\"author\":{\"name\":\"Vassia Lagou\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9\"},\"headline\":\"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar\",\"datePublished\":\"2022-12-15T11:12:00+00:00\",\"dateModified\":\"2024-03-04T15:08:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\"},\"wordCount\":236,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg\",\"articleSection\":[\"Uncategorized @ro\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\",\"url\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\",\"name\":\"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg\",\"datePublished\":\"2022-12-15T11:12:00+00:00\",\"dateModified\":\"2024-03-04T15:08:59+00:00\",\"description\":\"Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg\",\"width\":2560,\"height\":1440,\"caption\":\"Abstract of digital DNA construction. Science animation. Conceptual design of genetics information.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/ro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/ro\/#website\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"name\":\"Genekor\",\"description\":\"Medicina personalizat\u0103\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/ro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/ro\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/ro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9\",\"name\":\"Vassia Lagou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g\",\"caption\":\"Vassia Lagou\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar - Genekor","description":"Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/","og_locale":"ro_RO","og_type":"article","og_title":"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar","og_description":"Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.","og_url":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2022-12-15T11:12:00+00:00","article_modified_time":"2024-03-04T15:08:59+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg","type":"image\/jpeg"}],"author":"Vassia Lagou","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"Vassia Lagou","Timp estimat pentru citire":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/"},"author":{"name":"Vassia Lagou","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9"},"headline":"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar","datePublished":"2022-12-15T11:12:00+00:00","dateModified":"2024-03-04T15:08:59+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/"},"wordCount":236,"commentCount":0,"publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"image":{"@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg","articleSection":["Uncategorized @ro"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/","url":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/","name":"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg","datePublished":"2022-12-15T11:12:00+00:00","dateModified":"2024-03-04T15:08:59+00:00","description":"Studiul echipei \u0219tiin\u021bifice Genekor privind \u201eScorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel mutigenic pentru cancerul ereditar\u201d a fost prezentat \u00een cadrul Simpozionului de cancer mamar din San Antonio 2022 sub forma unui poster.","breadcrumb":{"@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2023\/12\/Polygenic-Risk-Score-in-a-cohort-of-105-Breast-Cancer-patients-previously-tested-with-a-multi-gene-panel-for-hereditary-cancer_1-scaled.jpeg","width":2560,"height":1440,"caption":"Abstract of digital DNA construction. Science animation. Conceptual design of genetics information."},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/ro\/2022\/12\/15\/scorul-de-risc-poligenic-intr-o-cohorta-de-105-de-pacienti-cu-cancer-mamar-testati-anterior-cu-un-panel-multigenic-pentru-cancer-ereditar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/ro\/"},{"@type":"ListItem","position":2,"name":"Scorul de risc poligenic \u00eentr-o cohort\u0103 de 105 de pacien\u021bi cu cancer mamar testa\u021bi anterior cu un panel multigenic pentru cancer ereditar"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/ro\/#website","url":"https:\/\/genekor.com\/ro\/","name":"Genekor","description":"Medicina personalizat\u0103","publisher":{"@id":"https:\/\/genekor.com\/ro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Organization","@id":"https:\/\/genekor.com\/ro\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/ro\/","logo":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/ro\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/3838490dbf25d05d55cf7ef7334c3bb9","name":"Vassia Lagou","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/genekor.com\/ro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84a701805a13ebdb019a482f93ba3be4?s=96&d=mm&r=g","caption":"Vassia Lagou"}}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/6078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/comments?post=6078"}],"version-history":[{"count":5,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/6078\/revisions"}],"predecessor-version":[{"id":9057,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/posts\/6078\/revisions\/9057"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media\/6079"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/media?parent=6078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/categories?post=6078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/ro\/wp-json\/wp\/v2\/tags?post=6078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}